Field Notes
From the Research team at Mirabilis Health.
Why Norway Matters: Ketamine and the Question of Who Gets to Heal
In August 2025, Norway became the first country in the world to offer publicly funded ketamine treatment for treatment-resistant depression. It is a landmark moment for psychiatry, and a question worth asking: what took so long, and what does it mean for the rest of us?
